Co-Pays For GLP-1 Weight Loss Drugs To Rise If They’re Even Covered
- Posted on May 24, 2026
- By Forbes
- 0 Views
- 1 min read
Co-Pays For GLP-1 Weight Loss Drugs To Rise If They’re Even Covered
GLP-1 weight loss drugs like Ozempic, Zepbound and Wegovy are the biggest contributor to rising prescription spending. And that will trigger co-payments to rise.